Charles River Laboratories International, Inc. (CRL)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 221.81 |
| Open | 224.27 |
| Bid | 202.00 x 900 |
| Ask | 245.00 x 1100 |
| Day's range | 225.63 - 233.91 |
| 52-week range | 161.65 - 275.00 |
| Volume | |
| Avg. volume | 512,909 |
| Market cap | 12.026B |
| Beta (5Y monthly) | 1.38 |
| PE ratio (TTM) | 27.40 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Here's How Charles River (CRL) is Placed Ahead of Q2 Earnings
Growth across Microbial Solutions and Biologics Testing and CDMO businesses is likely to have contributed to Charles River's (CRL) Q2 revenues, offset by lower biopharmaceutical demand.
- Simply Wall St.
Those who invested in Charles River Laboratories International (NYSE:CRL) five years ago are up 50%
It hasn't been the best quarter for Charles River Laboratories International, Inc. ( NYSE:CRL ) shareholders, since the...
- Zacks
Charles River (CRL) Teams Up to Aid Stargardt's Disease Therapy
Charles River (CRL) signs an agreement with AAVantgarde to produce GMP plasmid DNA for Stargardt's disease program.
© 2024 Yahoo. All rights reserved.